Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluate the Immunogenicity, Reactogenicity, Safety of 4 Different Formulations of GSK Biologicals' Conjugate Vaccine (MenACWY) vs 1 Dose of MenC-CRM197 or Mencevax™ ACWY in Children Aged 12-14 Months & 3-5 Years

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00196976
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:54.125317+00:00
Published At
2017-03-01T00:00:00+00:00
Record Updated At
2018-06-08
Results Posted At
2017-03-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Infections, Meningococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-06-08"
protocolSection.identificationModule.nctId
"NCT00196976"
protocolSection.identificationModule.officialTitle
"Evaluate the Immunogenicity, Reactogenicity, Safety of 4 Different Formulations of GSK Biologicals\u0027 Conjugate Vaccine (MenACWY) vs 1 Dose of MenC-CRM197 or Mencevax\u2122 ACWY in Children Aged 12-14 Months \u0026 3-5 Years"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-03-01"

Study condition terms

  • Infections, Meningococcal (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.